BR112013032777A2 - composição de sapogenol de soja - Google Patents

composição de sapogenol de soja

Info

Publication number
BR112013032777A2
BR112013032777A2 BR112013032777A BR112013032777A BR112013032777A2 BR 112013032777 A2 BR112013032777 A2 BR 112013032777A2 BR 112013032777 A BR112013032777 A BR 112013032777A BR 112013032777 A BR112013032777 A BR 112013032777A BR 112013032777 A2 BR112013032777 A2 BR 112013032777A2
Authority
BR
Brazil
Prior art keywords
sapogenol
soybean
composition
soy
soybean sapogenol
Prior art date
Application number
BR112013032777A
Other languages
English (en)
Portuguese (pt)
Inventor
Shuichi Kamo
Shunsuke Suzuki
Toshiro Sato
Original Assignee
J Oil Mills Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J Oil Mills Inc filed Critical J Oil Mills Inc
Publication of BR112013032777A2 publication Critical patent/BR112013032777A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
BR112013032777A 2011-06-28 2012-04-11 composição de sapogenol de soja BR112013032777A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011142434 2011-06-28
PCT/JP2012/059845 WO2013001890A1 (ja) 2011-06-28 2012-04-11 ソーヤサポゲノール組成物

Publications (1)

Publication Number Publication Date
BR112013032777A2 true BR112013032777A2 (pt) 2017-01-24

Family

ID=47423798

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013032777A BR112013032777A2 (pt) 2011-06-28 2012-04-11 composição de sapogenol de soja

Country Status (9)

Country Link
US (1) US9216187B2 (enExample)
EP (1) EP2727586A4 (enExample)
JP (2) JP6018571B2 (enExample)
KR (1) KR20140037107A (enExample)
CN (1) CN103635184B (enExample)
BR (1) BR112013032777A2 (enExample)
IN (1) IN2013CN09358A (enExample)
TW (1) TWI445536B (enExample)
WO (1) WO2013001890A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104487061B (zh) * 2012-07-24 2017-11-07 J-制油株式会社 组合物
KR101556849B1 (ko) 2014-04-25 2015-10-02 경희대학교 산학협력단 소야사포닌-i을 포함하는 신경줄기세포 또는 신경전구세포의 분화 또는 증식 촉진용 조성물
KR102406000B1 (ko) * 2015-09-30 2022-06-08 (주)아모레퍼시픽 소야사포닌을 함유하는 발모 및/또는 육모 촉진용 조성물
KR102417301B1 (ko) * 2015-10-30 2022-07-06 (주)아모레퍼시픽 소야사포닌을 함유하는 피부 미백용 조성물
CN112055544A (zh) * 2018-04-27 2020-12-08 三得利控股株式会社 抑制肌肉量减少用、抑制肌力下降用、增加肌肉量用或增加肌力用的组合物
CN108558985B (zh) * 2018-05-19 2019-06-07 河南省科学院高新技术研究中心 白桦脂酸衍生物及其合成方法和应用
WO2021085291A1 (ja) * 2019-10-30 2021-05-06 サントリーホールディングス株式会社 Ｔｇｒ５活性化用組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822120B2 (ja) * 1978-03-31 1983-05-06 大塚製薬株式会社 ３−０−（β−Ｄ−グルクロノピラノシル）−ソ−ヤサポゲノ−ルＢ
JPH10234396A (ja) * 1997-02-25 1998-09-08 Nippon Kayaku Co Ltd 新規抗腫瘍剤およびソヤサポゲノールｂの製造法
FR2779058B1 (fr) 1998-05-29 2003-02-21 Dior Christian Parfums Utilisation d'au moins une saponine ou un sapogenol cosmetiquement acceptable, comme agent cosmetique destine a augmenter la quantite de collagene iv dans la jonction dermo-epidermique
JP2000078955A (ja) * 1998-06-23 2000-03-21 Ezaki Glico Co Ltd 飲食物および薬品
JP2002128663A (ja) * 2000-10-19 2002-05-09 Kikkoman Corp ソヤサポゲノールｂを有効成分とする抗アレルギー剤
JP2005137201A (ja) 2001-04-16 2005-06-02 Meiji Seika Kaisha Ltd ソヤサポゲノールｂの製造法
CN1982444A (zh) 2001-06-06 2007-06-20 明治制果株式会社 皂草苷分解酶及其基因以及大豆皂草精醇b的大量生产系统
JP3670609B2 (ja) * 2001-12-25 2005-07-13 株式会社大阪薬品研究所 ダイズサポニン類誘導体を含有した抗酸化剤
US7638643B2 (en) 2002-03-14 2009-12-29 Fuji Oil Company, Limited Process for producing soybean saponin-containing material
JP2006213649A (ja) 2005-02-03 2006-08-17 Osaka Yakuhin Kenkyusho:Kk 大豆サポニンからなる細胞賦活剤、コラーゲン産生促進剤及び抗酸化剤、並びに該細胞賦活剤、該コラーゲン産生促進剤及び／又は該抗酸化剤を含有する化粧料原料、並びに該化粧料原料を含有する化粧料組成物
WO2008155890A1 (ja) 2007-06-21 2008-12-24 J-Oil Mills, Inc. 配糖体アグリコンの製造方法
JP5419366B2 (ja) * 2008-03-03 2014-02-19 東洋精糖株式会社 生体吸収性に優れたヘスペレチン組成物
WO2010150612A1 (ja) 2009-06-22 2010-12-29 株式会社Ｊ－オイルミルズ ヒアルロン酸産生促進剤及びメラニン生成抑制剤
JP5133373B2 (ja) * 2010-07-05 2013-01-30 株式会社ファンケル ベータグルコシダーゼ活性増強剤及び生理活性配糖体の吸収促進剤

Also Published As

Publication number Publication date
US20140121177A1 (en) 2014-05-01
TW201328696A (zh) 2013-07-16
EP2727586A1 (en) 2014-05-07
EP2727586A4 (en) 2014-11-26
JP2016193941A (ja) 2016-11-17
WO2013001890A1 (ja) 2013-01-03
TWI445536B (zh) 2014-07-21
JP6140347B2 (ja) 2017-05-31
CN103635184A (zh) 2014-03-12
JPWO2013001890A1 (ja) 2015-02-23
IN2013CN09358A (enExample) 2015-08-14
US9216187B2 (en) 2015-12-22
JP6018571B2 (ja) 2016-11-02
CN103635184B (zh) 2016-02-10
KR20140037107A (ko) 2014-03-26

Similar Documents

Publication Publication Date Title
BR112013032777A2 (pt) composição de sapogenol de soja
AR053827A1 (es) Composiciones de tigeciclina y metodos de preparacion
AR121611A2 (es) Inhibidores de glucosilceramida sintasa
BR112013023876A2 (pt) derivados de pirroltriazinona como inibidores de pi3k
CR20140392A (es) Dihidropirazolonas sustituidas
NI201300035A (es) Derivados de quinazolin - 4 (3h) - ona utilizados como inhibidores de pi3 cinasa
BR112013020609A2 (pt) 2-hidróxi-4-(metiltio) butironitrila estável em armazenamento
BR112015014333A2 (pt) compostos antivirais
BR112012000804B8 (pt) composição seca para mistura com água, solução aquosa, kit e composição de dose unitária para mistura com água
BR112014007917A2 (pt) reparo para fixação de raiz do menisco
BRPI0409229A (pt) inibidores das fosfodiesterases na infertilidade
MX2014000201A (es) Composiciones y metodos para mejorar el estado bioenergetico en celulas germinales femeninas.
BR112015015031A2 (pt) processo de glicoconjugação
ECSP099750A (es) Imidazoquinolinas con propiedades inmunomoduladoras
CR20110318A (es) Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos
BR112014001802A2 (pt) fluido de manutenção de poço e método de manutenção de poço com fluido
BR112014017650A2 (pt) composições e uso de ésteres de forbol
CO6690816A2 (es) Derivados de quinazolin-4(3h)-ona utilizados como inhibidores de pi3 cinasa
ECSP099296A (es) Inmuno-reguladores, preparaciones y composiciones que incluyen los inmuno-reguladores, pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y métodos
BR112013033388A2 (pt) composição cimentícia e mistura
BR112015007295A2 (pt) processo para a preparação de compostos; compostos; e uso dos mesmos
BRPI0701684A (pt) composição cosmética ou farmacêutica, processo de tratamento cosmético, uso de um composto e composto
BR112014000843A2 (pt) Uso de picosulfato para preparação de composição intestinal para o cálculo da duração de colonoscopia, composição intestinal e kit
CO2024000890A2 (es) Compuestos de heteroarilo para tratar la enfermedad de huntington
BR112015021147A2 (pt) métodos e detergentes enzimáticos para remoção de biomembranas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/704 (2006.01), A23L 33/10 (2016.01), A61K

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]